Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 1Q Financial Report: SFBC International | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

1Q Financial Report: SFBC International

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

SFBC International

1Q Revenues: $110 million (+14%)

1Q Loss: $4 million* (earnings were $5 million 1Q2005)

Comments: Early Clinical Development segment revenues were approximately $33 million, or 41% of total revenues, down 20%. The loss from operations for Early Clinical Development was approximately $5.6 million, representing a (17.0)% operating margin on revenue. Late Clinical Development segment revenues were approximately $47 million, or 59% of total revenue, up 31%. Earnings from operations for Late Clinical Development were approximately $7.5 million, up 103%.

*As a result of weak revenues, operating results and outlook for its Miami and Fort Myers, FL facilities, the company recorded pre-tax, non-cash goodwill and long-lived asset impairment charges of approximately $7.1 million in the quarter.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters